Sales rise 41.90% to Rs 4128.00 crore
Net profit of Torrent Pharmaceuticals declined 26.91% to Rs 364.00 crore in the quarter ended March 2026 as against Rs 498.00 crore during the previous quarter ended March 2025. Sales rose 41.90% to Rs 4128.00 crore in the quarter ended March 2026 as against Rs 2909.00 crore during the previous quarter ended March 2025.
For the full year,net profit rose 11.88% to Rs 2138.00 crore in the year ended March 2026 as against Rs 1911.00 crore during the previous year ended March 2025. Sales rose 21.53% to Rs 13753.00 crore in the year ended March 2026 as against Rs 11317.00 crore during the previous year ended March 2025.
ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.Sales4128.002909.00 42 13753.0011317.00 22 OPM %32.8533.14 –33.1532.88 – PBDT1103.00890.00 24 4080.003492.00 17 PBT595.00689.00 -14 2961.002697.00 10 NP364.00498.00 -27 2138.001911.00 12
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: May 22 2026 | 6:31 PM IST